# AbbVie Bioresearch Center – FDA Inspection, May 24, 2018

Source: https://www.keypedia.com/records/fda_inspections/abbvie-bioresearch-center/af6c0040-d422-4837-951e-f4145a5230be
Source feed: FDA_Inspections

> FDA inspection 1056813 of AbbVie Bioresearch Center, May 24, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1056813
- Company Name: AbbVie Bioresearch Center
- Inspection Date: 2018-05-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1295502 - 2025-12-16](https://www.keypedia.com/records/fda_inspections/abbvie-bioresearch-center/9cda06b1-831d-4b36-857f-63c6870cb2f2)
- FDA Inspection 1272372 - 2025-09-05
- [FDA Inspection 1252835 - 2024-01-30](https://www.keypedia.com/records/fda_inspections/abbvie-bioresearch-center/ce4a7b12-128c-4d9d-ae43-62d59d3877a3)
- FDA Inspection 1113080 - 2019-11-18
- FDA Inspection 1010336 - 2017-04-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/debra-m-emerson/58bd7fac-28eb-4369-b149-13a24cc00cf7)

Company: https://www.keypedia.com/companies/abbvie-bioresearch-center/6957449c-4de8-444b-b53c-5838b33a76a1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d